[Angiocyclan in the treatment of vascular diseases. Controlled clinical results].
D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy; D001161:Arteriosclerosis / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D003925:Diabetic Angiopathies / Q000188:drug therapy; D004617:Embolism / Q000188:drug therapy; D005260:Female; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy; D007511:Ischemia / Q000188:drug therapy; D007546:Isoquinolines / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D013927:Thrombosis / Q000188:drug therapy; D014652:Vascular Diseases / Q000188:drug therapy*
D005343:Fibrinolytic Agents; D007546:Isoquinolines
L'angiociclan nel trattamento delle vasculopatie. Risultati clinici controllati